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Objective: To examine tumour stage at diagnosis, treatment, patient and provider delays to diagnosis/treatment and survival of South
Asian patients with breast cancer in Yorkshire in comparison with the general population. Design: Retrospective study, using
Yorkshire Cancer Registry population-based data on breast cancer. Data on 16879 women with breast cancer diagnosed between
1986 and 1994 was available, of which 120 patients were South Asian. All-cause survival, controlling for age, socio-economic profile,
tumour stage and treatment was examined. Effects of ethnicity on tumour stage at diagnosis, treatment, patient and provider delays
to diagnosis and treatment were described. Over the period 1986–1994, an increase in the number of registered South Asian
patients with breast cancer was observed. South Asian patients were significantly younger at the time of diagnosis and presented with
larger primary tumours. They received similar treatment to non-Asian patients, but a higher mastectomy rate was noted. South Asian
patients’ survival, after controlling for age differences was similar to non-South Asian patients. South Asian patients had a significantly
longer patient-related delay between initial symptoms and presentation to GP and a slightly longer provider-related delay in time to
diagnosis and treatment. In conclusion, outcomes of breast cancer treatment in South Asian patients were similar to non-Asian
patients. Asian patients presented later to their GPs, with larger primary tumours and more frequently had mastectomy.
British Journal of Cancer (2004) 90, 1926–1932. doi:10.1038/sj.bjc.6601795 www.bjcancer.com
Published online 20 April 2004
& 2004 Cancer Research UK
Keywords: breast cancer; survival; ethnicity; South Asian; treatment delays
                                                 
South Asian minority ethnic groups make up to 3% of the
population of England (Office for National Statistics, 1996). Cancer
is a common cause of death in this population (Bahl, 1996; Wild
and McKeigue, 1997). A cross-sectional analysis of mortality by
country of birth revealed that although ischaemic heart disease was
the leading cause of death in the South Asian population (causing
4230 deaths during the period 1989–1992), lung and breast cancers
caused a significant number of deaths (n¼697) (Wild and
McKeigue, 1997).
Research in this area is difficult because data on ethnicity were
not routinely collected on hospital records until 1995 and so
identification of South Asian patients is problematic. Most often
epidemiological studies use country of birth to identify ethnic
minority population, recognising that this approach excludes
second-generation immigrants. Standardised mortality ratios
based on country of birth suggest lower mortality from breast
cancer in South Asian women (Wild and McKeigue, 1997;
Swerdlow et al, 1995). In a study using names to identify South
Asian patients in cancer registries, breast cancer incidence in
South Asian women was found to be lower than the general
population (Winter et al, 1999).
Breast cancer remains the most commonly diagnosed female
cancer in the UK, accounting for 34% of all cancers in Asian
women and 28% in non-Asian (Winter et al, 1999). Concerns exist
that minority ethnic groups may be getting suboptimal cancer
care. For example, the uptake of breast cancer screening is
relatively low (Bahl, 1996; Hoare, 1996). Large studies from the
USA show ethnic differences in survival after breast cancer, with
survival among African-American women significantly worse than
white women (Eley et al, 1994). The outcomes of breast cancer
treatment in ethnic minority groups in the UK have rarely been
formally studied (Selby, 1996; McKinney et al., 1999). One recent
study examined 10 year survival from breast cancer in South Asian
women from South East England and found higher relative
survival in comparison with the non-South Asian population
(Dos Santos Silva et al, 2003).
The purpose of this project was to detect possible delays in
diagnosis, differences in treatment and in outcomes in South Asian
breast cancer patients from Yorkshire, using the Yorkshire Cancer
Registry dataset (now part of the Northern and Yorkshire Cancer
Registry and Information Services). The hypotheses were based on
the extensive studies of outcomes by ethnicity in the USA, as at the
time of initiation of the project no data from UK was available. It
was hypothesised that the South Asian community in the UK
might have poorer survival from breast cancer in comparison with
the non-Asian population. The specific aims were to describe the
effects of ethnicity on tumour stage at diagnosis, delivered
treatment and patient and provider delays to diagnosis and
treatment (as a surrogate measure of patient access to hospital
treatment). The effects of ethnic group on patient survival were
examined, controlling for age, socio-economic profile, tumour
stage and treatment.
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lPATIENTS AND METHODS
Identification of Asian patients
We used data from the former Yorkshire Cancer Registry, serving
a population of 3. 6 million people for the time period 1986–1994.
South Asian was defined as a person with ethnic origin in either
Pakistan, India or Bangladesh. This definition includes Asians
from the Indian sub-continent and from East Africa and Sri Lanka
whose origins were in the Indian subcontinent. The Registry did
not routinely record the ethnic origin of patients and this
information was available in only approximately 4% of the cases.
Data on religion and birthplace was recorded for 69 and 58% of
cases.
Selection of South Asian patients was achieved using a
combined strategy of identifying South Asian names, independent
selection of cases based on data on ethnic origin, birthplace and
religion and final visual inspection of the combined data sets.
Initially, the Registry’s entire data set was scanned against Nam
Pehchan software to identify partial or complete matches against
the programme’s built-in dictionary of South Asian names (Nam
Pehchan computer software Version 1.1, Bradford Health Author-
ity) (Cummins et al, 1999). Second, all cases with available and
matching ethnic origin (Pakistani, Indian, Bangladeshi), birthplace
(Pakistan, Indian, Bangladesh, Sri Lanka, East Africa) and religion
(Sikh, Hindu, Moslem, other) were selected from the full list of
cancer registrations. The two data sets were matched and the
resulting list of names, plus information on birthplace, religion,
ethnicity was submitted to two reviewers (GV, LB) for final
classification. The reviewers rated the cases independently,
using books with lists of names as references (Schimmel, 1989;
Patel, 1992). The inter-rater agreement was good with Kappa
coefficient 0.84. Cases of disagreement and undetermined cases
were reviewed by four colleagues of Asian ethnic origin to achieve
consensus.
Once South Asian patients were identified, the Standardised
Incidence Rate Ratio comparing South Asian with non-South
Asian patients was calculated using population data for Yorkshire
from 1991 Census. The result was compared with data from other
studies in the UK.
Demographic and tumour data
Patient age was categorised into four age groups: p49, 50–64, 65–
74 and X75 years. In addition, for survival analysis age was split
into two groups below and above 50 years. These age groups are
frequently used as a surrogate measure of menopausal status.
Socio-economic status was characterised using the ward level
Carstairs Index scores (Dale and Marsh, 1993). The ward level
Carstairs Index scores ranged from  5.13 to 17.63, with a mean
score of 0. Positive scores indicate greater levels of deprivation. For
analysis purposes, the scores were grouped into the quartiles o 2,
 2t oo0, 0 to o3, above 3.
The Registry collects information on tumour size, regional
lymph nodes, histologic grade, treatment and patient and provider
delays (Sainsbury et al, 1999). Tumour size was grouped as p2cm
and 42cm. Grade was defined as well, moderately or poorly
differentiated. Treatment modalities were grouped as surgery (with
separate measurement of mastectomy rate and surgeon workload),
radiotherapy, hormonotherapy and chemotherapy. The Yorkshire
Cancer Registry records key dates of first symptoms, GP referral,
first visit at hospital and start of definitive treatment. We
calculated the time from the symptom date to GP referral to
reflect patient-related delay (groups p60 and 460 days) and the
time from GP referral to the first hospital visit (p14 and 414
days) and from the first hospital visit to the definitive treatment
(p14 and 414 days) to reflect provider delay. The cut-off points
were selected to reflect the pattern of data, current standard of
cancer care and systematic reviews of effects of delays on breast
cancer outcomes (Sainsbury et al, 1995).
As the years of the study included 1988 when the NHS Breast
Screening Programme was introduced, information was collected
on number of patients screened.
Survival was calculated from the date of registration. Patients
still alive at the time of the study were censored at 1st January
1999. Initial inspection of survival data revealed a higher
proportion of censored data in the Asian patients in comparison
with non-Asian for several cancer sites, including breast (69%
censored data vs 52%, respectively). Additional active follow-up
was performed for all Asian patients and for a random sample of
non-Asian patients. Patient status was checked at the correspond-
ing Health Authorities, and if still ‘alive’ letters were sent to GPs
with a request for information. The local Ethics committee gave
permission to contact patients’ GPs. After the active follow-up,
definitive information on patient status was obtained for 94% of
Asian breast cancer patients and for 98% of non-Asian patients.
Statistical analysis
Analyses of association between ethnic groups and demographic,
tumour and treatment variables were performed using frequency
tables and w
2 statistic. When calculating w
2 statistic cases with
missing values were excluded. Mean age of Asian and non-Asian
patients was compared with a t-test.
Previous research suggests that variations in the quality of
cancer care between health districts account for late diagnosis,
treatment and outcome differences (Sainsbury et al, 1995). Socio-
economic differences in breast cancer survival have been reported
for England and Wales (Coleman et al, 1999). Therefore, logistic
regression was used to control for the possible effects of socio-
economic status, hospital district and patient age, when analysing
the effect of ethnicity on cancer stage at diagnosis and treatment
modalities. The models included cancer stage (or treatment) as the
dependent binary variable and socio-economic status, hospital
district, patient age and ethnicity (South Asian vs non-Asian) as
independent variables.
Survival curves were estimated by the Kaplan–Meier method
and compared using log-rank test. Cox’s proportional hazards
regression analysis was used to compare survival by ethnicity, with
allowance for other factors – age, tumour size/nodal status, tumour
grade and treatment.
Significance level was set at 1% to allow for multiple
comparisons. The analyses were performed with SPSS Version
11.0 for Windows (SPSS Inc, Chicago, IL, USA) and SAS version
6.07 (SAS Institute Inc, Cary, NC, USA).
RESULTS
Breast cancer registrations, socio-demographic and
tumour characteristics
Information on 16879 patients with breast cancer from 1986 to
1994 was available and 120 (0. 7%) were identified as South Asian.
The Standardised Incidence Rate Ratio in this study comparing
South Asian with non-South Asian patients was 0.56 (95% CI 0.46–
0.66).
From the ethnic minority patients 31% lived in Bradford area,
24% in Leeds, 18% in Dewsbury and 12% in Huddersfield.
Descriptions of the demographic, socio-economic and tumour
characteristics of the patients, stratified by ethnicity are presented
in Table 1. In 1986–1994, there was an increase in the number of
registered South Asian patients with breast cancer. The rate of
increase is higher than for non-Asian women (Po0.004). Asian
women were significantly younger than non-Asian at the time of
diagnosis of breast cancer (mean age 49.7 vs 62.0 years,
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lrespectively, Po0.0001), with a greater proportion being less than
50 years old.
A significantly larger proportion of South Asian breast cancer
patients belonged to the deprived socio-economic groups (Car-
stairs Index above 3). A significantly higher proportions of South
Asian patients presented with tumours larger than 2cm. The
differences remained after controlling for socio-economic status,
age and hospital district (Table 1). The proportions of patients
with involved regional lymph nodes and with poorly differentiated
tumours were not significantly different. The differences in
tumour-related variables should be interpreted with caution due
to the large amount of missing data.
The Registry data showed that 7.5% (n¼9) South Asian patients
8.8% (n¼1469) non-Asian patients, diagnosed with breast cancer,
participated in breast screening. The information on breast
screening was not included in any further analysis due to the
small number of South Asian patients.
Time to GP presentation, referral pattern and treatment
modalities (Table 2)
All patients had their first hospital visit date recorded, 67% had GP
referral date (n¼11285) and 44% of the patients (n¼7433) had
symptom date recorded. Asian patients had longer period between
the onset of symptoms and GP presentation (median of 61 days vs
a median of 31 days for non-Asian women, P¼0.005 after
controlling for age and hospital district) (Table 2). Controlling for
socio-economic status did not explain the ethnic differences in
presentation (data not shown). There was no significant difference
in the period between the GP referral and the first hospital visit,
using the a priori stated definition of Po0.01. Significantly larger
proportion of non-Asian patients had definitive treatment within 2
weeks of first hospital visit (Po0.0001). However, the median time
to treatment in South Asian patients was only 14 vs 9 days in non-
Asian patients. A difference in the order of less than 1 week is
unlikely to have an impact on treatment results (Table 2).
The use of any surgery was similar in Asian and non-Asian
patients, but a significantly higher mastectomy rate was found for
Asian patients, after controlling for age and district of residence
(to account for regional differences in surgical practices). As
tumour characteristics like size and nodal status are expected to
influence treatment, an additional subgroup analysis was per-
formed comparing the mastectomy rate in node-positive patients
and in patients with tumours larger than 2cm, controlling for age.
Mastectomy rate did not differ significantly between South Asian
and non-Asian patients who had large tumours or positive lymph
nodes. Therefore, ethnicity in itself did not appear to be associated
with different surgical treatment. These results should be
interpreted with extreme caution due to the large amount of
missing data on nodal status and tumour size. Only 49 South Asian
patients had positive lymph nodes and only 35 South Asian
patients had tumours larger than 2cm. However, it appears that
the higher mastectomy rate most likely reflects more advanced
tumours at presentation, requiring radical surgery, rather than
different treatment approach to South Asian patients.
Table 1 Demographic, socio-economic and tumour characteristics of the patients stratified by ethnicity
Non-Asian Asian
Variables Number Percent Number Percent P-value
a (v
2 statistic) P-value
b logistic regression)
Year period
1986–1988 5069 30 24 20 0.004 —
1989–1991 5756 34 39 33
1992–1994 5934 35 57 48
Total 16759 100 120 100
Age (years)
o50 3683 22 66 55 o0.0001 —
50–4 5731 34 33 28
65–74 3661 22 16 13
75+ 3684 22 5 4
Carstairs Index
o  2 (affluent) 4177 25 9 8 o0.0001 —
 2t oo0 4252 26 14 12
0t oo3 3810 23 16 13
3+(deprived) 4254 26 81 68
Unknown (19) (0.1)
Tumour size
p2cm 3187 56
c 19 35 0.002 0.002
42cm 2528 44 35 65
Unknown (11044) (66)
d (66) (55)
Involvement of regional lymph nodes
Negative nodal involvement 2591 34
c 14 22 0.054 0.45
Known involvement 5083 66 49 78
Unknown (9085) (54)
d (57) (48)
Tumour grade
Well 1190 13
c 4 5 0.028 0.08
Moderately 2810 31 23 27
Poorly differentiated 5015 56 57 68
Unknown (7744) (46)
d (36) (30)
aP-values from w
2 statistic, excluding cases with missing data.
bLogistic regression controlling for age, hospital district and Carstairs Index.
cPercentage calculated on the basis of
available data only.
dProportion of missing data.
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lThe use of radiotherapy was similar in both groups. A larger
proportion of Asian patients received chemotherapy, but after
adjustment for age and district the differences were not significant.
The use of hormonotherapy treatment appeared similar in both
groups, but after adjustment for age and hospital district a
significantly higher use of hormonotherapy was noted in the Asian
patients.
Survival
In the univariate analysis, a marginally favourable survival
advantage was observed for the Asian patients in comparison
with non-Asian (Figure 1, p¼0.043). However, examination of
survival by age groups (o50 vs X50years) revealed no significant
differences. The small differences observed for all patients seemed
related to the larger proportion of young patients in the ethnic
minority group. The multivariate analysis (Table 3) confirmed that
patient age explained the small difference in overall survival in
favour of Asian patients. Controlling for socio-economic depriva-
tion suggested that South Asian patients living in deprived areas
had better survival, compared to non-Asian patients. However,
when age was included in the model, controlling for the other case
mix factors (disease and treatment characteristics) did not have an
effect on survival. In a model including all possible explanatory
variables, only controlling for age changed the estimates, thus
suggesting that the small difference in survival of South Asian
patients can be explained by their younger age and not by any of
the other variables (socio-economic deprivation, tumour stage or
treatment) (Figure 2).
DISCUSSION
This study described the state of breast cancer in the Yorkshire
South Asian population in terms of socio-demographic character-
istics of patients, stage of disease, treatment and outcomes,
including long-term survival. Over the period 1986–1994, there
Table 2 Time to GP presentation, referral pattern and treatment
Non-Asian Asian
Number Percent Number Percent P-value
a (v
2 statistic) P-value
b (logistic regression)
1st symptom to GP presentation
p60 days 3734 66
c 16 47 0.017 0.005
460 days 1889 34 18 53
median (days) 31 61
Unknown (11136) (67)
d (86) (72)
GP referral to 1st hospital visit
p14 days 7127 64
c 49 52 0.049 0.028
414 days 4062 36 46 48
median (days) 11 14
Unknown (5570) (33) (25) (21)
1st hospital visit to treatment
p14 days 10322 63
c 47 39 o0.0001 o0.0001
414 days 6113 37 72 61
median (days) 9 14
Unknown (144) (0.9) 1 (0)
Treatment
Any surgery
Yes 14034 84 111 93 0.08 0.16
No 2711 16 9 8
Unknown (14) (0) (0) (0)
Mastectomy rate
Yes 8155 49 75 63 0.003 0.007
No 8604 51 45 38
Unknown (0) (0) (0) (0)
Radiotherapy
Yes 8119 49 63 53 0.57 0.37
No 8444 50 57 48
Unknown (194) (1) (0) (0)
Chemotherapy
Yes 2566 15 38 32 o0.0001 0.15
No 13934 83 82 68
Unknown (258) (2) (0) (0)
Hormonotherapy
Yes 12862 77 93 78 0.59 0.01
No 3752 22 27 23
Unknown (145) (1) (0) (0)
aP-values from w
2 statistic, excluding cases with missing data.
bLogistic regression controlling for socio-economic status, age and hospital district.
cPercentage calculated on the
basis of available data only.
dProportion of missing data.
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lwas an increase in the number of registered South Asian patients
with breast cancer. These results are consistent with other studies,
showing increased incidence rates of breast cancer in South Asian
women over time, while the rates decreased among non-Asian
population (Winter et al, 1999; Dos Santos Silva et al, 2003; Smith
et al, 2003). These changes could be explained by the ageing
population of South Asians, increased proportion of second-
generation immigrants and significant differences in lifestyle and
other exposures occurring in South Asian minority population in
the UK.
South Asian patients were significantly younger at the time of
diagnosis. This finding is likely to reflect the generally younger age
of ethnic minorities in Britain (Office for National Statistics, 1996).
It is consistent with observations in ethnic minority groups both in
the UK and the USA (African-American women) (Coates et al,
1992; Elmore et al, 1998; Joslyn and West, 2000; Dos Santos Silva
et al, 2003; Smith et al, 2003).
South Asian women presented with larger tumours, with the
difference remaining statistically significant after adjustment for
age and hospital district. Similar observations were reported from
research in the USA (Elmore et al, 1998; Hunter, 2000). The trend
for more advanced stage at diagnosis is consistent with the longer
interval found between first symptoms of breast cancer and
presentation to the GP. The observed higher mastectomy rate also
suggests that more radical surgery may have been required to
achieve adequate local control. These findings are consistent with
other research showing lower uptake of breast screening
programmes by ethnic minority populations (Hoare, 1996).
Possible cultural differences and different attitudes to cancer
could account for these important observations (Bottorff et al,
1998; Lannin et al, 1998; Tam et al, 2003). Interventions aimed at
increasing breast cancer awareness and encouraging breast
screening could be recommended.
After controlling for age, survival of South Asian women was
essentially similar to non-Asian breast cancer patients. No
significant effect was found for any of the case-mix factors studied
(including socio-economic status, disease stage at presentation,
treatment and consultants work load). Our findings are similar to
those of Dos Santos Silva et al (2003), who found higher relative
survival of South Asian women with breast cancer (RR 0.82, 95%
CI 0.72–0.94, P¼0.004), and adjustment for age at diagnosis
reduced the magnitude of the difference (RR 0.88, 95% CI 0.78–
1.01, P¼0.07). However, in their study adjustment for stage and
socio-economic deprivation strengthened the survival difference.
In contrast to these findings from UK, extensive research from
the USA suggested significantly poorer survival in African
Americans (Eley et al, 1994). However, in a study comparing
breast cancer patients who had equivalent stage disease and were
Figure 1 All-cause survival curves by ethnicity
Figure 2 All cause survival curves by ethnicity and age
Table 3 A 5-year relative risk of death among South Asian breast cancer
patients compared with the general population, unadjusted and after
adjustment for demographic, tumour and treatment-related variables (Cox
Proportional Hazards model)
Adjustment
Relative risk
of death for
South Asians 95% CI
None (ethnicity alone) 0.74 0.54 0.99
Plus age 1.01 0.75 1.36
Plus tumour size, grade 0.75 0.55 1.01
Plus treatment 0.87 0.64 1.17
Plus workload 0.78 0.58 1.05
Plus carstairs index 0.68 0.50 0.91
Plus age 1.01 0.75 1.36
Plus age, tumour size, grade 0.98 0.71 1.33
Plus age, tumour size, treatment 0.97 0.71 1.29
Plus age, tumour size, treatment, consultant
workload
0.95 0.71 1.29
Plus age, tumour size, treatment, consultant
workload, carstairs index
0.89 0.66 1.21
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ltreated uniformly in a single institution, race did not influence
outcome (Heimann et al, 1997). Furthermore, there is a
documented survival advantage of Japanese patients and equiva-
lent survival of Chinese patients compared to Caucasians and
these findings remain unexplained (Clegg et al, 2002; Tam
et al, 2003).
No clinically meaningful differences were identified in provider-
related delay between the South Asian and the non-Asian patients
with breast cancer. Furthermore, the recorded data on definitive
treatment for breast cancer showed no significant differences in
the active anticancer treatment, apart from a higher mastectomy
rate. Therefore, this study did not support the hypothesis that
Asian patients may have poorer access to hospital treatment, but a
concern remains about the more advanced stage of disease at
presentation. These results are difficult to compare with other data
on ethnic minorities in the UK and further research should be
encouraged.
Several limitations of the present study should be discussed,
particularly in relation to the use of retrospective data from Cancer
Registry and the methods for selection of South Asian patients. As
routine collection of data on patient ethnic origin started only in
1995, we had to use alternative methods for identifying South
Asian patients with breast cancer. A rigorous procedure for
selection of South Asian patients was employed following
suggestions from other researchers (Cummins et al, 1999).
However, the possibility of error due to the software not
identifying rare South Asian names or to the large amount of
missing data on birthplace and religion cannot be excluded.
Nevertheless, it is our belief that this approach was the only
feasible way of identifying South Asian patients in order to
conduct this study. As an external validation of this approach, the
standardised Incidence Rate Ratio was calculated 0.56 (95% CI
0.46–0.66), which was found to be similar to the rate, reported by
Smith et al (2003) (0.61, 95% CI 0.50–0.73) and Winter et al (1999)
(0.64, 95% CI 0.59–0.69). It should be noted that we identified
0.7% of registered breast cancer cases as South Asian, whereas
other authors identified slightly higher proportions – Dos Santos
et al (2003) identified 1.9% of breast cancer registrations as South
Asian, Winter et al (1999) – 1.3%.
The use of retrospective Registry data had the advantage of a
large population-based database, but the disadvantage of not
having complete staging information on all cases and no records of
prognostic information, such as hormone receptor status. When
examining survival, hormone receptor status is an important
prognostic factor and the lack of that information may potentially
lead to erroneous conclusions. The missing data on tumour size
and lymph nodal status makes the interpretation of the results
difficult and cautious. Although the Registry database of breast
cancer patients was large (above 16000 cases), the number of
South Asian patients identified was relatively small (only 120),
which made the investigation of the effect of various case-mix
factors difficult.
The study raised some concerns about the validity of death
information among South Asian women, derived from Office of
National Statistics data. Initial observations showed significantly
higher proportion of censored cases for South Asian patients with
all types of cancer. This led to the hypothesis that terminally ill
patients may return to their country of birth and their deaths
would not be recorded. This hypothesis was explored by active
follow-up of all South Asian patients, and for comparative
purposes a random sample of non-South Asian patients. For the
breast cancer cases, the active follow-up did not contribute
significantly more information and following this rigorous quality
assurance procedure, the survival data for the breast cancer
patients can be considered reliable.
In conclusion, South Asian patients with breast cancer were
found to have more advanced disease at diagnosis and possibly to
present later to their GP when they had breast symptoms. The
multimodality treatment of breast cancer and the outcomes of
treatment and survival were similar to those of non-Asian patients.
The limitations of using a retrospective data set from Cancer
Registry should be recognised. However, large prospective national
studies would be difficult and expensive to perform and alternative
strategies should be considered. Repeated retrospective analyses at
regular intervals (i.e. every 10 years), using existing Cancer
Registries databases can be performed to detect changes in the
pattern of presentation, treatment and outcomes of cancer in
ethnic minorities.
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